Patents by Inventor Zhai Li

Zhai Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating polycystic kidney disease
    Patent number: 9457016
    Abstract: Methods for treating autosomal dominant polycystic kidney disease (ADPKD) are described herein. More particularly, methods described herein relate generally to administering glutaminase1 inhibitors to subjects afflicted with ADPKD. Accordingly, the use and application of compounds or agents that inhibit glutaminase1 for treating ADPKD or for use in a medicament for treating ADPKD are encompassed herein.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: October 4, 2016
    Assignee: New York University
    Inventors: Edward Skolnik, Zhai Li
  • PHOSPHATIDYLINOSITOL-3-KINASE C2 BETA MODULATORS AND METHODS OF USE THEREOF
    Publication number: 20150204846
    Abstract: Methods for screening to identify agents capable of modulating PI3KC2?/mast cell activation are also encompassed herein as are methods of using such agents to treat IgE-mediated allergic disorders.
    Type: Application
    Filed: May 15, 2013
    Publication date: July 23, 2015
    Inventors: Edward Skolnik, Zhai Li, Shekhar Srivastava
  • METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE
    Publication number: 20150065486
    Abstract: Methods for treating autosomal dominant polycystic kidney disease (ADPKD) are described herein. More particularly, methods described herein relate generally to administering glutaminase1 inhibitors to subjects afflicted with ADPKD. Accordingly, the use and application of compounds or agents that inhibit glutaminase1 for treating ADPKD or for use in a medicament for treating ADPKD are encompassed herein.
    Type: Application
    Filed: August 29, 2014
    Publication date: March 5, 2015
    Inventors: Edward Skolnik, Zhai Li